This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

PhRMA says order in FTC case over AndroGel goes too far

( June 12, 2019, 20:31 GMT | Official Statement) -- MLex Summary: The Pharmaceutical Research and Manufacturers of America has filed an amicus brief urging the US Court of Appeals for the Third Circuit to find that AbbVie, Abbott Laboratories, Unimed Pharmaceuticals and Besins Healthcare did not engage in sham patent litigation related to the drug AndroGel. PhRMA says the district court’s analysis constitutes a drastic expansion of the sham litigation exception to the Noerr-Pennington doctrine, and conflicts with the Supreme Court’s narrow articulation of the exception. “Adoption of the district court’s reasoning would undermine the robust patent protections that are critical to innovation in the biopharmaceutical industry, and could have serious negative consequences for scientific progress, public health, and the economy.”See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections